1 Study Coverage 1.1 Biopharma Buffer Product Introduction 1.2 Market by Type 1.2.1 Global Biopharma Buffer Market Size Growth Rate by Type 1.4.2 Phosphates Type 1.4.3 Acetates Type 1.2.4 TRIS Type 1.2.5 Others 1.3 Market by Application 1.3.1 Global Biopharma Buffer Market Size Growth Rate by Application 1.3.2 Research Institution 1.3.3 Pharmaceutical Industry 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Biopharma Buffer Sales Estimates and Forecasts 2016-2027 2.2 Global Biopharma Buffer Revenue Estimates and Forecasts 2016-2027 2.3 Global Biopharma Buffer Revenue by Region: 2016 VS 2021 VS 2027 2.4 Global Top Biopharma Buffer Regions by Sales 2.4.1 Global Top Biopharma Buffer Regions by Sales (2016-2021) 2.4.2 Global Top Biopharma Buffer Regions by Sales (2022-2027) 2.5 Global Top Biopharma Buffer Regions by Revenue 2.5.1 Global Top Biopharma Buffer Regions by Revenue (2016-2021) 2.5.2 Global Top Biopharma Buffer Regions by Revenue (2022-2027) 2.6 North America 2.7 Europe 2.8 Asia-Pacific 2.9 Latin America 2.10 Middle East & Africa 3 Competition by Manufacturers 3.1 Global Biopharma Buffer Sales by Manufacturers 3.1.1 Global Top Biopharma Buffer Manufacturers by Sales (2016-2021) 3.1.2 Global Top Biopharma Buffer Manufacturers Market Share by Sales (2016-2021) 3.1.3 Global Top 10 and Top 5 Companies by Biopharma Buffer Sales in 2020 3.2 Global Biopharma Buffer Revenue by Manufacturers 3.2.1 Global Top Biopharma Buffer Manufacturers by Revenue (2016-2021) 3.2.2 Global Top Biopharma Buffer Manufacturers Market Share by Revenue (2016-2021) 3.2.3 Global Top 10 and Top 5 Companies by Biopharma Buffer Revenue in 2020 3.3 Global Biopharma Buffer Sales Price by Manufacturers 3.4 Analysis of Competitive Landscape 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Biopharma Buffer Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4.3 Global Biopharma Buffer Manufacturers Geographical Distribution 3.5 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Global Biopharma Buffer Sales by Type 4.1.1 Global Biopharma Buffer Historical Sales by Type (2016-2021) 4.1.2 Global Biopharma Buffer Forecasted Sales by Type (2022-2027) 4.1.3 Global Biopharma Buffer Sales Market Share by Type (2016-2027) 4.2 Global Biopharma Buffer Revenue by Type 4.2.1 Global Biopharma Buffer Historical Revenue by Type (2016-2021) 4.2.2 Global Biopharma Buffer Forecasted Revenue by Type (2022-2027) 4.2.3 Global Biopharma Buffer Revenue Market Share by Type (2016-2027) 4.3 Global Biopharma Buffer Price by Type 4.3.1 Global Biopharma Buffer Price by Type (2016-2021) 4.3.2 Global Biopharma Buffer Price Forecast by Type (2022-2027) 5 Market Size by Application 5.1 Global Biopharma Buffer Sales by Application 5.1.1 Global Biopharma Buffer Historical Sales by Application (2016-2021) 5.1.2 Global Biopharma Buffer Forecasted Sales by Application (2022-2027) 5.1.3 Global Biopharma Buffer Sales Market Share by Application (2016-2027) 5.2 Global Biopharma Buffer Revenue by Application 5.2.1 Global Biopharma Buffer Historical Revenue by Application (2016-2021) 5.2.2 Global Biopharma Buffer Forecasted Revenue by Application (2022-2027) 5.2.3 Global Biopharma Buffer Revenue Market Share by Application (2016-2027) 5.3 Global Biopharma Buffer Price by Application 5.3.1 Global Biopharma Buffer Price by Application (2016-2021) 5.3.2 Global Biopharma Buffer Price Forecast by Application (2022-2027) 6 North America 6.1 North America Biopharma Buffer Market Size by Type 6.1.1 North America Biopharma Buffer Sales by Type (2016-2027) 6.1.2 North America Biopharma Buffer Revenue by Type (2016-2027) 6.2 North America Biopharma Buffer Market Size by Application 6.2.1 North America Biopharma Buffer Sales by Application (2016-2027) 6.2.2 North America Biopharma Buffer Revenue by Application (2016-2027) 6.3 North America Biopharma Buffer Market Size by Country 6.3.1 North America Biopharma Buffer Sales by Country (2016-2027) 6.3.2 North America Biopharma Buffer Revenue by Country (2016-2027) 6.3.3 U.S. 6.3.4 Canada 7 Europe 7.1 Europe Biopharma Buffer Market Size by Type 7.1.1 Europe Biopharma Buffer Sales by Type (2017-2027) 7.1.2 Europe Biopharma Buffer Revenue by Type (2017-2027) 7.2 Europe Biopharma Buffer Market Size by Application 7.2.1 Europe Biopharma Buffer Sales by Application (2017-2027) 7.2.2 Europe Biopharma Buffer Revenue by Application (2017-2027) 7.3 Europe Biopharma Buffer Market Size by Country 7.3.1 Europe Biopharma Buffer Sales by Country (2017-2027) 7.3.2 Europe Biopharma Buffer Revenue by Country (2017-2027) 7.3.3 Germany 7.3.4 France 7.3.5 U.K. 7.3.6 Italy 7.3.7 Russia 8 Asia Pacific 8.1 Asia Pacific Biopharma Buffer Market Size by Type 8.1.1 Asia Pacific Biopharma Buffer Sales by Type (2018-2027) 8.1.2 Asia Pacific Biopharma Buffer Revenue by Type (2018-2027) 8.2 Asia Pacific Biopharma Buffer Market Size by Application 8.2.1 Asia Pacific Biopharma Buffer Sales by Application (2018-2027) 8.2.2 Asia Pacific Biopharma Buffer Revenue by Application (2018-2027) 8.3 Asia Pacific Biopharma Buffer Market Size by Region 8.3.1 Asia Pacific Biopharma Buffer Sales by Region (2018-2027) 8.3.2 Asia Pacific Biopharma Buffer Revenue by Region (2018-2027) 8.3.3 China 8.3.4 Japan 8.3.5 South Korea 8.3.6 India 8.3.7 Australia 8.3.8 Taiwan 8.3.9 Indonesia 8.3.10 Thailand 8.3.11 Malaysia 8.3.12 Philippines 9 Latin America 9.1 Latin America Biopharma Buffer Market Size by Type 9.1.1 Latin America Biopharma Buffer Sales by Type (2019-2027) 9.1.2 Latin America Biopharma Buffer Revenue by Type (2019-2027) 9.2 Latin America Biopharma Buffer Market Size by Application 9.2.1 Latin America Biopharma Buffer Sales by Application (2019-2027) 9.2.2 Latin America Biopharma Buffer Revenue by Application (2019-2027) 9.3 Latin America Biopharma Buffer Market Size by Country 9.3.1 Latin America Biopharma Buffer Sales by Country (2019-2027) 9.3.2 Latin America Biopharma Buffer Revenue by Country (2019-2027) 9.3.3 Mexico 9.3.4 Brazil 9.3.5 Argentina 6 Middle East and Africa 6.1 Middle East and Africa Biopharma Buffer Market Size by Type 6.1.1 Middle East and Africa Biopharma Buffer Sales by Type (2016-2027) 6.1.2 Middle East and Africa Biopharma Buffer Revenue by Type (2016-2027) 6.2 Middle East and Africa Biopharma Buffer Market Size by Application 6.2.1 Middle East and Africa Biopharma Buffer Sales by Application (2016-2027) 6.2.2 Middle East and Africa Biopharma Buffer Revenue by Application (2016-2027) 6.3 Middle East and Africa Biopharma Buffer Market Size by Country 6.3.1 Middle East and Africa Biopharma Buffer Sales by Country (2016-2027) 6.3.2 Middle East and Africa Biopharma Buffer Revenue by Country (2016-2027) 6.3.3 Turkey 6.3.4 Saudi Arabia 6.3.5 UAE 11 Company Profiles 11.1 Avantor 11.1.1 Avantor Corporation Information 11.1.2 Avantor Overview 11.1.3 Avantor Biopharma Buffer Sales, Price, Revenue and Gross Margin (2016-2021) 11.1.4 Avantor Biopharma Buffer Product Description 11.1.5 Avantor Related Developments 11.2 Alfa Aesar (Thermo Fisher) 11.2.1 Alfa Aesar (Thermo Fisher) Corporation Information 11.2.2 Alfa Aesar (Thermo Fisher) Overview 11.2.3 Alfa Aesar (Thermo Fisher) Biopharma Buffer Sales, Price, Revenue and Gross Margin (2016-2021) 11.2.4 Alfa Aesar (Thermo Fisher) Biopharma Buffer Product Description 11.2.5 Alfa Aesar (Thermo Fisher) Related Developments 11.3 Merck 11.3.1 Merck Corporation Information 11.3.2 Merck Overview 11.3.3 Merck Biopharma Buffer Sales, Price, Revenue and Gross Margin (2016-2021) 11.3.4 Merck Biopharma Buffer Product Description 11.3.5 Merck Related Developments 11.4 Lonza 11.4.1 Lonza Corporation Information 11.4.2 Lonza Overview 11.4.3 Lonza Biopharma Buffer Sales, Price, Revenue and Gross Margin (2016-2021) 11.4.4 Lonza Biopharma Buffer Product Description 11.4.5 Lonza Related Developments 11.5 Bio-Rad 11.5.1 Bio-Rad Corporation Information 11.5.2 Bio-Rad Overview 11.5.3 Bio-Rad Biopharma Buffer Sales, Price, Revenue and Gross Margin (2016-2021) 11.5.4 Bio-Rad Biopharma Buffer Product Description 11.5.5 Bio-Rad Related Developments 11.6 BD 11.6.1 BD Corporation Information 11.6.2 BD Overview 11.6.3 BD Biopharma Buffer Sales, Price, Revenue and Gross Margin (2016-2021) 11.6.4 BD Biopharma Buffer Product Description 11.6.5 BD Related Developments 11.7 GE Healthcare 11.7.1 GE Healthcare Corporation Information 11.7.2 GE Healthcare Overview 11.7.3 GE Healthcare Biopharma Buffer Sales, Price, Revenue and Gross Margin (2016-2021) 11.7.4 GE Healthcare Biopharma Buffer Product Description 11.7.5 GE Healthcare Related Developments 11.8 Promega Corporation 11.8.1 Promega Corporation Corporation Information 11.8.2 Promega Corporation Overview 11.8.3 Promega Corporation Biopharma Buffer Sales, Price, Revenue and Gross Margin (2016-2021) 11.8.4 Promega Corporation Biopharma Buffer Product Description 11.8.5 Promega Corporation Related Developments 11.9 Hamilton Company 11.9.1 Hamilton Company Corporation Information 11.9.2 Hamilton Company Overview 11.9.3 Hamilton Company Biopharma Buffer Sales, Price, Revenue and Gross Margin (2016-2021) 11.9.4 Hamilton Company Biopharma Buffer Product Description 11.9.5 Hamilton Company Related Developments 11.10 XZL BIO-TECHNOLOGY 11.10.1 XZL BIO-TECHNOLOGY Corporation Information 11.10.2 XZL BIO-TECHNOLOGY Overview 11.10.3 XZL BIO-TECHNOLOGY Biopharma Buffer Sales, Price, Revenue and Gross Margin (2016-2021) 11.10.4 XZL BIO-TECHNOLOGY Biopharma Buffer Product Description 11.10.5 XZL BIO-TECHNOLOGY Related Developments 11.1 Avantor 11.1.1 Avantor Corporation Information 11.1.2 Avantor Overview 11.1.3 Avantor Biopharma Buffer Sales, Price, Revenue and Gross Margin (2016-2021) 11.1.4 Avantor Biopharma Buffer Product Description 11.1.5 Avantor Related Developments 12 Value Chain and Sales Channels Analysis 12.1 Biopharma Buffer Value Chain Analysis 12.2 Biopharma Buffer Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Biopharma Buffer Production Mode & Process 12.4 Biopharma Buffer Sales and Marketing 12.4.1 Biopharma Buffer Sales Channels 12.4.2 Biopharma Buffer Distributors 12.5 Biopharma Buffer Customers 13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 13.1 Biopharma Buffer Industry Trends 13.2 Biopharma Buffer Market Drivers 13.3 Biopharma Buffer Market Challenges 13.4 Biopharma Buffer Market Restraints 14 Key Findings in The Global Biopharma Buffer Study 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer

List of Tables Table 1. Global Biopharma Buffer Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of Phosphates Type Table 3. Major Manufacturers of Acetates Type Table 4. Major Manufacturers of TRIS Type Table 5. Major Manufacturers of Others Table 6. Global Biopharma Buffer Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million) Table 7. Global Biopharma Buffer Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million) Table 8. Global Biopharma Buffer Sales by Region (2016-2021) & (KL) Table 9. Global Biopharma Buffer Sales Market Share by Region (2016-2021) Table 10. Global Biopharma Buffer Sales by Region (2016-2021) & (KL) Table 11. Global Biopharma Buffer Sales Market Share by Region (2022-2027) Table 12. Global Biopharma Buffer Revenue by Region (2016-2021) & (US$ Million) Table 13. Global Biopharma Buffer Revenue Market Share by Region (2016-2021) Table 14. Global Biopharma Buffer Revenue by Region (2022-2027) & (US$ Million) Table 15. Global Biopharma Buffer Revenue Market Share by Region (2022-2027) Table 16. Global Biopharma Buffer Sales by Manufacturers (2016-2021) & (KL) Table 17. Global Biopharma Buffer Sales Share by Manufacturers (2016-2021) Table 18. Global Biopharma Buffer Revenue by Manufacturers (2016-2021) & (US$ Million) Table 19. Global Biopharma Buffer Revenue Share by Manufacturers (2016-2021) Table 20. Biopharma Buffer Price by Manufacturers 2016-2021 (US$/L) Table 21. Global Biopharma Buffer Manufacturers Market Concentration Ratio (CR5 and HHI) Table 22. Global Biopharma Buffer by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharma Buffer as of 2020) Table 23. Biopharma Buffer Manufacturing Base Distribution and Headquarters Table 24. Manufacturers Biopharma Buffer Product Offered Table 25. Date of Manufacturers Enter into Biopharma Buffer Market Table 26. Mergers & Acquisitions, Expansion Plans Table 27. Global Biopharma Buffer Sales by Type (2016-2021) & (KL) Table 28. Global Biopharma Buffer Sales by Type (2022-2027) & (KL) Table 29. Global Biopharma Buffer Sales Share by Type (2016-2021) Table 30. Global Biopharma Buffer Sales Share by Type (2022-2027) Table 31. Global Biopharma Buffer Revenue by Type (2016-2021) & (US$ Million) Table 32. Global Biopharma Buffer Revenue by Type (2022-2027) & (US$ Million) Table 33. Global Biopharma Buffer Revenue Share by Type (2016-2021) Table 34. Global Biopharma Buffer Revenue Share by Type (2022-2027) Table 35. Biopharma Buffer Price by Type (2016-2021) & (US$/L) Table 36. Global Biopharma Buffer Price Forecast by Type (2022-2027) & (US$/L) Table 37. Global Biopharma Buffer Sales by Application (2016-2021) & (KL) Table 38. Global Biopharma Buffer Sales by Application (2022-2027) & (KL) Table 39. Global Biopharma Buffer Sales Share by Application (2016-2021) Table 40. Global Biopharma Buffer Sales Share by Application (2022-2027) Table 41. Global Biopharma Buffer Revenue by Application (2016-2021) & (US$ Million) Table 42. Global Biopharma Buffer Revenue by Application (2022-2027) & (US$ Million) Table 43. Global Biopharma Buffer Revenue Share by Application (2016-2021) Table 44. Global Biopharma Buffer Revenue Share by Application (2022-2027) Table 45. Biopharma Buffer Price by Application (2016-2021) & (US$/L) Table 46. Global Biopharma Buffer Price Forecast by Application (2022-2027) & (US$/L) Table 47. North America Biopharma Buffer Sales by Type (2016-2021) & (KL) Table 48. North America Biopharma Buffer Sales by Type (2022-2027) & (KL) Table 49. North America Biopharma Buffer Revenue by Type (2016-2021) & (US$ Million) Table 50. North America Biopharma Buffer Revenue by Type (2022-2027) & (US$ Million) Table 51. North America Biopharma Buffer Sales by Application (2016-2021) & (KL) Table 52. North America Biopharma Buffer Sales by Application (2022-2027) & (KL) Table 53. North America Biopharma Buffer Revenue by Application (2016-2021) & (US$ Million) Table 54. North America Biopharma Buffer Revenue by Application (2022-2027) & (US$ Million) Table 55. North America Biopharma Buffer Sales by Country (2016-2021) & (KL) Table 56. North America Biopharma Buffer Sales by Country (2022-2027) & (KL) Table 57. North America Biopharma Buffer Revenue by Country (2016-2021) & (US$ Million) Table 58. North America Biopharma Buffer Revenue by Country (2022-2027) & (US$ Million) Table 59. Europe Biopharma Buffer Sales by Type (2016-2021) & (KL) Table 60. Europe Biopharma Buffer Sales by Type (2022-2027) & (KL) Table 61. Europe Biopharma Buffer Revenue by Type (2016-2021) & (US$ Million) Table 62. Europe Biopharma Buffer Revenue by Type (2022-2027) & (US$ Million) Table 63. Europe Biopharma Buffer Sales by Application (2016-2021) & (KL) Table 64. Europe Biopharma Buffer Sales by Application (2022-2027) & (KL) Table 65. Europe Biopharma Buffer Revenue by Application (2016-2021) & (US$ Million) Table 66. Europe Biopharma Buffer Revenue by Application (2022-2027) & (US$ Million) Table 67. Europe Biopharma Buffer Sales by Country (2016-2021) & (KL) Table 68. Europe Biopharma Buffer Sales by Country (2022-2027) & (KL) Table 69. Europe Biopharma Buffer Revenue by Country (2016-2021) & (US$ Million) Table 70. Europe Biopharma Buffer Revenue by Country (2022-2027) & (US$ Million) Table 71. Asia Pacific Biopharma Buffer Sales by Type (2016-2021) & (KL) Table 72. Asia Pacific Biopharma Buffer Sales by Type (2022-2027) & (KL) Table 73. Asia Pacific Biopharma Buffer Revenue by Type (2016-2021) & (US$ Million) Table 74. Asia Pacific Biopharma Buffer Revenue by Type (2022-2027) & (US$ Million) Table 75. Asia Pacific Biopharma Buffer Sales by Application (2016-2021) & (KL) Table 76. Asia Pacific Biopharma Buffer Sales by Application (2022-2027) & (KL) Table 77. Asia Pacific Biopharma Buffer Revenue by Application (2016-2021) & (US$ Million) Table 78. Asia Pacific Biopharma Buffer Revenue by Application (2022-2027) & (US$ Million) Table 79. Asia Pacific Biopharma Buffer Sales by Region (2016-2021) & (KL) Table 80. Asia Pacific Biopharma Buffer Sales by Region (2022-2027) & (KL) Table 81. Asia Pacific Biopharma Buffer Revenue by Region (2016-2021) & (US$ Million) Table 82. Asia Pacific Biopharma Buffer Revenue by Region (2022-2027) & (US$ Million) Table 83. Latin America Biopharma Buffer Sales by Type (2016-2021) & (KL) Table 84. Latin America Biopharma Buffer Sales by Type (2022-2027) & (KL) Table 85. Latin America Biopharma Buffer Revenue by Type (2016-2021) & (US$ Million) Table 86. Latin America Biopharma Buffer Revenue by Type (2022-2027) & (US$ Million) Table 87. Latin America Biopharma Buffer Sales by Application (2016-2021) & (KL) Table 88. Latin America Biopharma Buffer Sales by Application (2022-2027) & (KL) Table 89. Latin America Biopharma Buffer Revenue by Application (2016-2021) & (US$ Million) Table 90. Latin America Biopharma Buffer Revenue by Application (2022-2027) & (US$ Million) Table 91. Latin America Biopharma Buffer Sales by Country (2016-2021) & (KL) Table 92. Latin America Biopharma Buffer Sales by Country (2022-2027) & (KL) Table 93. Latin America Biopharma Buffer Revenue by Country (2016-2021) & (US$ Million) Table 94. Latin America Biopharma Buffer Revenue by Country (2022-2027) & (US$ Million) Table 95. Middle East and Africa Biopharma Buffer Sales by Type (2016-2021) & (KL) Table 96. Middle East and Africa Biopharma Buffer Sales by Type (2022-2027) & (KL) Table 97. Middle East and Africa Biopharma Buffer Revenue by Type (2016-2021) & (US$ Million) Table 98. Middle East and Africa Biopharma Buffer Revenue by Type (2022-2027) & (US$ Million) Table 99. Middle East and Africa Biopharma Buffer Sales by Application (2016-2021) & (KL) Table 100. Middle East and Africa Biopharma Buffer Sales by Application (2022-2027) & (KL) Table 101. Middle East and Africa Biopharma Buffer Revenue by Application (2016-2021) & (US$ Million) Table 102. Middle East and Africa Biopharma Buffer Revenue by Application (2022-2027) & (US$ Million) Table 103. Middle East and Africa Biopharma Buffer Sales by Country (2016-2021) & (KL) Table 104. Middle East and Africa Biopharma Buffer Sales by Country (2022-2027) & (KL) Table 105. Middle East and Africa Biopharma Buffer Revenue by Country (2016-2021) & (US$ Million) Table 106. Middle East and Africa Biopharma Buffer Revenue by Country (2022-2027) & (US$ Million) Table 107. Avantor Corporation Information Table 108. Avantor Description and Major Businesses Table 109. Avantor Biopharma Buffer Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2016-2021) Table 110. Avantor Biopharma Buffer Product Table 111. Avantor Recent Developments Table 112. Alfa Aesar (Thermo Fisher) Corporation Information Table 113. Alfa Aesar (Thermo Fisher) Description and Major Businesses Table 114. Alfa Aesar (Thermo Fisher) Biopharma Buffer Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2016-2021) Table 115. Alfa Aesar (Thermo Fisher) Biopharma Buffer Product Table 116. Alfa Aesar (Thermo Fisher) Recent Developments Table 117. Merck Corporation Information Table 118. Merck Description and Major Businesses Table 119. Merck Biopharma Buffer Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2016-2021) Table 120. Merck Biopharma Buffer Product Table 121. Merck Recent Developments Table 122. Lonza Corporation Information Table 123. Lonza Description and Major Businesses Table 124. Lonza Biopharma Buffer Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2016-2021) Table 125. Lonza Biopharma Buffer Product Table 126. Lonza Recent Developments Table 127. Bio-Rad Corporation Information Table 128. Bio-Rad Description and Major Businesses Table 129. Bio-Rad Biopharma Buffer Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2016-2021) Table 130. Bio-Rad Biopharma Buffer Product Table 131. Bio-Rad Recent Developments Table 132. BD Corporation Information Table 133. BD Description and Major Businesses Table 134. BD Biopharma Buffer Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2016-2021) Table 135. BD Biopharma Buffer Product Table 136. BD Recent Developments Table 137. GE Healthcare Corporation Information Table 138. GE Healthcare Description and Major Businesses Table 139. GE Healthcare Biopharma Buffer Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2016-2021) Table 140. GE Healthcare Biopharma Buffer Product Table 141. GE Healthcare Recent Developments Table 142. Promega Corporation Corporation Information Table 143. Promega Corporation Description and Major Businesses Table 144. Promega Corporation Biopharma Buffer Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2016-2021) Table 145. Promega Corporation Biopharma Buffer Product Table 146. Promega Corporation Recent Developments Table 147. Hamilton Company Corporation Information Table 148. Hamilton Company Description and Major Businesses Table 149. Hamilton Company Biopharma Buffer Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2016-2021) Table 150. Hamilton Company Biopharma Buffer Product Table 151. Hamilton Company Recent Developments Table 152. XZL BIO-TECHNOLOGY Corporation Information Table 153. XZL BIO-TECHNOLOGY Description and Major Businesses Table 154. XZL BIO-TECHNOLOGY Biopharma Buffer Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2016-2021) Table 155. XZL BIO-TECHNOLOGY Biopharma Buffer Product Table 156. XZL BIO-TECHNOLOGY Recent Developments Table 157. SRL Corporation Information Table 158. SRL Description and Major Businesses Table 159. SRL Biopharma Buffer Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2016-2021) Table 160. SRL Biopharma Buffer Product Table 161. SRL Recent Developments Table 162. Key Raw Materials Lists Table 163. Raw Materials Key Suppliers Lists Table 164. Biopharma Buffer Distributors List Table 165. Biopharma Buffer Customers List Table 166. Biopharma Buffer Market Trends Table 167. Biopharma Buffer Market Drivers Table 168. Biopharma Buffer Market Challenges Table 169. Biopharma Buffer Market Restraints Table 170. Research Programs/Design for This Report Table 171. Key Data Information from Secondary Sources Table 172. Key Data Information from Primary Sources List of Figures Figure 1. Biopharma Buffer Product Picture Figure 2. Global Biopharma Buffer Market Share by Type in 2020 & 2027 Figure 3. Phosphates Type Product Picture Figure 4. Acetates Type Product Picture Figure 5. TRIS Type Product Picture Figure 6. Others Product Picture Figure 7. Global Biopharma Buffer Sales Market Share by Application in 2020 & 2027 Figure 8. Research Institution Figure 9. Pharmaceutical Industry Figure 10. Others Figure 11. Biopharma Buffer Report Years Considered Figure 12. Global Biopharma Buffer Sales 2016-2027 (KL) Figure 13. Global Biopharma Buffer Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 14. Global Biopharma Buffer Revenue 2016-2027 (US$ Million) Figure 15. Global Biopharma Buffer Revenue Market Share by Region in Percentage: 2020 Versus 2027 Figure 16. Global Biopharma Buffer Sales Market Share by Region (2016-2021) Figure 17. Global Biopharma Buffer Sales Market Share by Region (2022-2027) Figure 18. North America Biopharma Buffer Sales YoY (2016-2027) & (KL) Figure 19. North America Biopharma Buffer Revenue YoY (2016-2027) & (US$ Million) Figure 20. Europe Biopharma Buffer Sales YoY (2016-2027) & (KL) Figure 21. Europe Biopharma Buffer Revenue YoY (2016-2027) & (US$ Million) Figure 22. Asia-Pacific Biopharma Buffer Sales YoY (2016-2027) & (KL) Figure 23. Asia-Pacific Biopharma Buffer Revenue YoY (2016-2027) & (US$ Million) Figure 24. Latin America Biopharma Buffer Sales YoY (2016-2027) & (KL) Figure 25. Latin America Biopharma Buffer Revenue YoY (2016-2027) & (US$ Million) Figure 26. Middle East & Africa Biopharma Buffer Sales YoY (2016-2027) & (KL) Figure 27. Middle East & Africa Biopharma Buffer Revenue YoY (2016-2027) & (US$ Million) Figure 28. The Top 10 and Top 5 Players Market Share by Biopharma Buffer Sales in 2020 Figure 29. The Top 10 and Top 5 Players Market Share by Biopharma Buffer Revenue in 2020 Figure 30. Biopharma Buffer Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020 Figure 31. Global Biopharma Buffer Sales Market Share by Type (2016-2027) Figure 32. Global Biopharma Buffer Revenue Market Share by Type (2016-2027) Figure 33. Global Biopharma Buffer Sales Market Share by Application (2016-2027) Figure 34. Global Biopharma Buffer Revenue Market Share by Application (2016-2027) Figure 35. North America Biopharma Buffer Sales Market Share by Type (2016-2027) Figure 36. North America Biopharma Buffer Revenue Market Share by Type (2016-2027) Figure 37. North America Biopharma Buffer Sales Market Share by Application (2016-2027) Figure 38. North America Biopharma Buffer Revenue Market Share by Application (2016-2027) Figure 39. North America Biopharma Buffer Sales Share by Country (2016-2027) Figure 40. North America Biopharma Buffer Revenue Share by Country (2016-2027) Figure 41. U.S. Biopharma Buffer Revenue (2016-2027) & (US$ Million) Figure 42. Canada Biopharma Buffer Revenue (2016-2027) & (US$ Million) Figure 43. Europe Biopharma Buffer Sales Market Share by Type (2016-2027) Figure 44. Europe Biopharma Buffer Revenue Market Share by Type (2016-2027) Figure 45. Europe Biopharma Buffer Sales Market Share by Application (2016-2027) Figure 46. Europe Biopharma Buffer Revenue Market Share by Application (2016-2027) Figure 47. Europe Biopharma Buffer Sales Share by Country (2016-2027) Figure 48. Europe Biopharma Buffer Revenue Share by Country (2016-2027) Figure 49. Germany Biopharma Buffer Revenue (2016-2027) & (US$ Million) Figure 50. France Biopharma Buffer Revenue (2016-2027) & (US$ Million) Figure 51. U.K. Biopharma Buffer Revenue (2016-2027) & (US$ Million) Figure 52. Italy Biopharma Buffer Revenue (2016-2027) & (US$ Million) Figure 53. Russia Biopharma Buffer Revenue (2016-2027) & (US$ Million) Figure 54. Asia Pacific Biopharma Buffer Sales Market Share by Type (2016-2027) Figure 55. Asia Pacific Biopharma Buffer Revenue Market Share by Type (2016-2027) Figure 56. Asia Pacific Biopharma Buffer Sales Market Share by Application (2016-2027) Figure 57. Asia Pacific Biopharma Buffer Revenue Market Share by Application (2016-2027) Figure 58. Asia Pacific Biopharma Buffer Sales Share by Region (2016-2027) Figure 59. Asia Pacific Biopharma Buffer Revenue Share by Region (2016-2027) Figure 60. China Biopharma Buffer Revenue (2016-2027) & (US$ Million) Figure 61. Japan Biopharma Buffer Revenue (2016-2027) & (US$ Million) Figure 62. South Korea Biopharma Buffer Revenue (2016-2027) & (US$ Million) Figure 63. India Biopharma Buffer Revenue (2016-2027) & (US$ Million) Figure 64. Australia Biopharma Buffer Revenue (2016-2027) & (US$ Million) Figure 65. Taiwan Biopharma Buffer Revenue (2016-2027) & (US$ Million) Figure 66. Indonesia Biopharma Buffer Revenue (2016-2027) & (US$ Million) Figure 67. Thailand Biopharma Buffer Revenue (2016-2027) & (US$ Million) Figure 68. Malaysia Biopharma Buffer Revenue (2016-2027) & (US$ Million) Figure 69. Philippines Biopharma Buffer Revenue (2016-2027) & (US$ Million) Figure 70. Latin America Biopharma Buffer Sales Market Share by Type (2016-2027) Figure 71. Latin America Biopharma Buffer Revenue Market Share by Type (2016-2027) Figure 72. Latin America Biopharma Buffer Sales Market Share by Application (2016-2027) Figure 73. Latin America Biopharma Buffer Revenue Market Share by Application (2016-2027) Figure 74. Latin America Biopharma Buffer Sales Share by Country (2016-2027) Figure 75. Latin America Biopharma Buffer Revenue Share by Country (2016-2027) Figure 76. Mexico Biopharma Buffer Revenue (2016-2027) & (US$ Million) Figure 77. Brazil Biopharma Buffer Revenue (2016-2027) & (US$ Million) Figure 78. Argentina Biopharma Buffer Revenue (2016-2027) & (US$ Million) Figure 79. Middle East and Africa Biopharma Buffer Sales Market Share by Type (2016-2027) Figure 80. Middle East and Africa Biopharma Buffer Revenue Market Share by Type (2016-2027) Figure 81. Middle East and Africa Biopharma Buffer Sales Market Share by Application (2016-2027) Figure 82. Middle East and Africa Biopharma Buffer Revenue Market Share by Application (2016-2027) Figure 83. Middle East and Africa Biopharma Buffer Sales Share by Country (2016-2027) Figure 84. Middle East and Africa Biopharma Buffer Revenue Share by Country (2016-2027) Figure 85. Turkey Biopharma Buffer Revenue (2016-2027) & (US$ Million) Figure 86. Saudi Arabia Biopharma Buffer Revenue (2016-2027) & (US$ Million) Figure 87. UAE Biopharma Buffer Revenue (2016-2027) & (US$ Million) Figure 88. Biopharma Buffer Value Chain Figure 89. Biopharma Buffer Production Process Figure 90. Channels of Distribution Figure 91. Distributors Profiles Figure 92. Bottom-up and Top-down Approaches for This Report Figure 93. Data Triangulation Figure 94. Key Executives Interviewed

Avantor Alfa Aesar (Thermo Fisher) Merck Lonza Bio-Rad BD GE Healthcare Promega Corporation Hamilton Company XZL BIO-TECHNOLOGY SRL